Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash	$ 519	$ 1,210
Prepaid expenses	746	746
Total current assets	1,265	1,956
Other assets, net	121,464	116,495
Patents, net	406,747	445,018
Total assets	529,476	563,469
CURRENT LIABILITIES:
Accounts payable	498,887	323,948
Convertible notes, net of discount 0 and $39,414 respectively	944,306	1,033,249
Derivative liability	1,320,184	1,275,500
Accrued Liabilities	588,693	497,078
Contract liability, related party	42,000	42,000
Related party notes payable	44,096	44,096
Total current liabilities	3,438,166	3,215,871
Secured Debenture	1,141,494	1,155,150
Total liabilities	4,579,660	4,371,021
Commitments and contingencies
STOCKHOLDERS' DEFICIT
Common stock (par value $0.01), 20,000,000,000 shares authorized, 3,394,817,156 and 1,392,042,112 shares issued and outstanding respectively	33,948,172	13,920,421
Treasury stock, 100,000 shares	(1,000)	(1,000)
Convertible preferred stock, Series D (par value $0.01) 100,000 shares authorized, 88,235 shares issued and outstanding respectively	883	883
Paid-in capital in excess of par value	(31,773,340)	(11,877,864)
Non-controlling interest in a variable interest entity and subsidiary	(12,439)	(12,439)
Accumulated other comprehensive income	350,429	336,775
Accumulated deficit	(6,562,889)	(6,174,328)
TOTAL STOCKHOLDERS' DEFICIT	(4,050,184)	(3,807,552)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 529,476	$ 563,469